Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Pia P. Vihinen

Department of Oncology and Radiotherapy

Turku University Hospital

PO Box 52

Fin-20521 Turku

Finland

[email]@tyks.fi

Name/email consistency: high

[Claim this account]

Affiliation

Department of Oncology and Radiotherapy, Turku University Hospital, PO Box 52, Fin-20521 Turku, Finland. 2002 - 2011

References

Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report. Vihinen, P., Paija, O., Kivisaari, A., Koulu, L., Aho, H. J. Med. Case. Reports (2011) [Pubmed]
A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma. Vihinen, P.P., Hernberg, M., Vuoristo, M.S., Tyynelä, K., Laukka, M., Lundin, J., Ivaska, J., Pyrhönen, S. Melanoma Res. (2010) [Pubmed]
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma. Vihinen, P., Koskivuo, I., Syrjänen, K., Tervahartiala, T., Sorsa, T., Pyrhönen, S. Melanoma Res. (2008) [Pubmed]
Serum angiogenin levels predict treatment response in patients with stage IV melanoma. Vihinen, P., Kallioinen, M., Vuoristo, M.S., Ivaska, J., Syrjänen, K.J., Hahka-Kemppinen, M., Kellokumpu-Lehtinen, P.L., Pyrhönen, S.O. Clin. Exp. Metastasis (2007) [Pubmed]
Serum VEGF-C is associated with metastatic site in patients with malignant melanoma. Vihinen, P.P., Hilli, J., Vuoristo, M.S., Syrjänen, K.J., Kähäri, V.M., Pyrhönen, S.O. Acta. Oncol (2007) [Pubmed]
Matrix metalloproteinases as therapeutic targets in cancer. Vihinen, P., Ala-aho, R., Kähäri, V.M. Curr. Cancer. Drug. Targets (2005) [Pubmed]
New prognostic factors and developing therapy of cutaneous melanoma. Vihinen, P.P., Pyrhönen, S.O., Kähäri, V.M. Ann. Med. (2003) [Pubmed]
Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue. Vihinen, P.P., Kätkä, K.M., Johansson, R.K., Vihinen, T.A., Salminen, E.K. Acta. Oncol (2003) [Pubmed]
Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Vihinen, P., Kähäri, V.M. Int. J. Cancer (2002) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.